{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:21:48Z","timestamp":1793186508837,"version":"4.5.0"},"reference-count":187,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Neuroimaging assessment of motor neuron disease has turned into a cornerstone of its clinical workup. Amyotrophic lateral sclerosis (ALS), as a paradigmatic motor neuron disease, has been extensively studied by advanced neuroimaging methods, including molecular imaging by MRI and PET, furthering finer and more specific details of the cascade of ALS neurodegeneration and symptoms, facilitated by multicentric studies implementing novel methodologies. With an increase in multimodal neuroimaging data on ALS and an exponential improvement in neuroimaging technology, the need for harmonization of protocols and integration of their respective findings into a consistent model becomes mandatory. Integration of multimodal data into a model of a continuing cascade of functional loss also calls for the best attempt to correlate the different molecular imaging measurements as performed at the shortest inter-modality time intervals possible. As outlined in this perspective article, simultaneous PET\/MRI, nowadays available at many neuroimaging research sites, offers the perspective of a one-stop shop for reproducible imaging biomarkers on neuronal damage and has the potential to become the new gold standard for characterizing motor neuron disease from the clinico-radiological and neuroscientific perspectives.<\/jats:p>","DOI":"10.3389\/fneur.2022.890425","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:45:31Z","timestamp":1660711531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Simultaneous PET\/MRI: The future gold standard for characterizing motor neuron disease\u2014A clinico-radiological and neuroscientific perspective"],"prefix":"10.3389","volume":"13","author":[{"given":"Freimut D.","family":"Juengling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wuest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schirrmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Thaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/WCO.0000000000000728","article-title":"Imaging in amyotrophic lateral sclerosis: MRI and pet","volume":"32","author":"Kassubek","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00259-016-3440-3","article-title":"A Pet\/Ct approach to spinal cord metabolism in amyotrophic lateral sclerosis","volume":"43","author":"Marini","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1109\/NSSMIC.2016.8069573","article-title":"FDG-PET and the assessment of spinal cord metabolism in amyotrophic lateral sclerosis (ALS)","author":"Massone","year":"2016","journal-title":"2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop (NSS\/MIC\/RTSD)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00259-018-4246-2","article-title":"Testing the diagnostic accuracy of [18f]Fdg-pet in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis","volume":"46","author":"Sala","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S1474-4422(14)70167-X","article-title":"Neuroimaging in amyotrophic lateral sclerosis: Insights into structural and functional changes","volume":"13","author":"Chi\u00f2","year":"2014","journal-title":"The Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1007\/s00415-020-10289-5","article-title":"The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?","volume":"268","author":"Chipika","year":"2021","journal-title":"J Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/jnnp-2015-311952","article-title":"A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis","volume":"87","author":"M\u00fcller","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B9","doi-asserted-by":"crossref","unstructured":"KalraS\n            KhanM\n            BarlowL\n            BeaulieuC\n            BenatarM\n            BriembergH\n          The Canadian Als Neuroimaging Consortium (Calsnic) - a Multicentre Platform for Standardized Imaging Clinical Studies in Als2020","DOI":"10.1101\/2020.07.10.20142679"},{"key":"B10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neuroimage.2018.01.034","article-title":"High resolution in-vivo diffusion imaging of the human hippocampus","volume":"182","author":"Treit","year":"2018","journal-title":"Neuroimage."},{"key":"B11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/14737175.2018.1463160","article-title":"Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses","volume":"18","author":"Agosta","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fneur.2019.00482","article-title":"Magnetic resonance spectroscopy in als","volume":"10","author":"Kalra","year":"2019","journal-title":"Front Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/MNM.0000000000000682","article-title":"Harmonizing standardized uptake value recovery between two Pet\/Ct systems from different manufacturers when using resolution modelling and time-of-flight","volume":"38","author":"Armstrong","year":"2017","journal-title":"Nucl Med Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1080\/0284186X.2017.1346824","article-title":"Quality assessment of positron emission tomography scans: recommendations for future multicentre trials","volume":"56","author":"de Jong","year":"2017","journal-title":"Acta Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"095019","DOI":"10.1088\/1361-6560\/aabb5f","article-title":"A novel approach for quantitative harmonization in pet","volume":"63","author":"Nam\u00edas","year":"2018","journal-title":"Phys Med Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235010","DOI":"10.1088\/1361-6560\/aaee27","article-title":"How to harmonize suvs obtained by hybrid Pet\/Ct scanners with and without point spread function correction","volume":"63","author":"Ferretti","year":"2018","journal-title":"Phys Med Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s00259-018-4033-0","article-title":"Clinical utility of Fdg-pet in amyotrophic lateral sclerosis and huntington's disease","volume":"45","author":"Agosta","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/WNL.0000000000002242","article-title":"18f-Fdg-pet correlates of cognitive impairment in Als","volume":"86","author":"Canosa","year":"2016","journal-title":"Neurology."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323876","article-title":"Metabolic brain changes across different levels of cognitive impairment in als: a (18)F-Fdg-pet study","author":"Canosa","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13550-018-0458-5","article-title":"Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from parkinson plus syndromes","volume":"8","author":"Devrome","year":"2018","journal-title":"Eur J Necl Med Mol Imaging Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/21678421.2018.1476548","article-title":"Multicenter validation of [(18)F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls","volume":"19","author":"D'Hulst","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00259-020-05053-w","article-title":"Brain metabolic changes across king's stages in amyotrophic lateral sclerosis: a (18)F-2-Fluoro-2-Deoxy-D-glucose-positron emission tomography study","volume":"48","author":"Canosa","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/ene.14637","article-title":"Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: an 18f-Fdg-positron emission tomography study","volume":"28","author":"Canosa","year":"2021","journal-title":"Eur J Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamaneurol.2020.1087","article-title":"Use of multimodal imaging and clinical biomarkers in presymptomatic carriers of C9orf72 repeat expansion","volume":"77","author":"De Vocht","year":"2020","journal-title":"JAMA Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s00259-021-05668-7","article-title":"Amyotrophic lateral sclerosis with sod1 mutations shows distinct brain metabolic changes","volume":"49","author":"Canosa","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","article-title":"Functional pattern of brain Fdg-pet in amyotrophic lateral sclerosis","volume":"83","author":"Pagani","year":"2014","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.121.262232","article-title":"Brain stem glucose hypermetabolism in amyotrophic lateral sclerosis\/frontotemporal dementia and shortened survival: an (18)F-Fdg Pet\/MRI Study","volume":"63","author":"Zanovello","year":"2022","journal-title":"J Nucl Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s004010000312","article-title":"Autoradiography with [3h]Pk11195 of spinal tract degeneration in amyotrophic lateral sclerosis","volume":"101","author":"Sitte","year":"2001","journal-title":"Acta Neuropathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11c](R)-Pk11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/syn.21765","article-title":"Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 Kda Radioligand, [18f]-Feppa","volume":"68","author":"Suridjan","year":"2014","journal-title":"Synapse."},{"key":"B31","article-title":"Preliminary results of pet with 18f-Dpa 714 in humans for detection of microglial activation in amyotrophic lateral sclerosis (Als)","author":"Le Pogam","year":"2008","journal-title":"J Nucl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ana.21796","article-title":"Multimodal microglia imaging of fiber tracts in acute subcortical stroke","volume":"66","author":"Radlinska","year":"2009","journal-title":"Ann Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.118.216747","volume":"60","author":"Koole","year":"2019","journal-title":"J Nucl Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00259-019-04550-x","article-title":"The P2x7 Receptor Tracer [11c]Smw139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study","volume":"47","author":"Hagens","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1096\/fj.14-268714","article-title":"The P2x7 receptor directly interacts with the Nlrp3 inflammasome scaffold protein","volume":"29","author":"Franceschini","year":"2015","journal-title":"FASEB J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"Cox-2, Cb2 and P2x7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-2094-7-33","article-title":"Extracellular Atp and the P2x7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis","volume":"7","author":"Gandelman","year":"2010","journal-title":"J Neuroinflamm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neulet.2016.07.039","article-title":"Down-regulation of purinergic P2x7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis","volume":"630","author":"Liu","year":"2016","journal-title":"Neurosci Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnmol.2020.00093","article-title":"P2x7 receptor antagonism as a potential therapy in amyotrophic lateral sclerosis","volume":"13","author":"Ruiz-Ruiz","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","article-title":"In situ click chemistry generation of cyclooxygenase-2 inhibitors","volume":"8","author":"Bhardwaj","year":"2017","journal-title":"Natu Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nucmedbio.2018.05.001","article-title":"Impact of structural alterations on the radiopharmacological profile of 18f-Labeled pyrimidines as cyclooxygenase-2 (Cox-2) imaging agents","author":"Tietz","year":"2018","journal-title":"Nucl Med Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1021\/acs.molpharmaceut.9b00986","article-title":"Radiosynthesis and biological evaluation of [18 F]triacoxib: a new radiotracer for pet imaging of Cox-2","volume":"17","author":"Litchfield","year":"2020","journal-title":"Mol Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphys.2020.00063","article-title":"Antioxidant alternatives in the treatment of amyotrophic lateral sclerosis: a comprehensive review","volume":"11","author":"Carrera-Juli\u00e1","year":"2020","journal-title":"Front Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2020.00279","article-title":"The peripheral immune system and amyotrophic lateral sclerosis","volume":"11","author":"McCombe","year":"2020","journal-title":"Front Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/jnr.21398","article-title":"Impaired Sdf1\/Cxcr4 signaling in glial progenitors derived from Sod1(G93a) mice","volume":"85","author":"Luo","year":"2007","journal-title":"J Neurosci Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12974-018-1135-3","article-title":"Dysregulation of chemokine receptor expression and function in leukocytes from als patients","volume":"15","author":"Perner","year":"2018","journal-title":"J Neuroinflamm."},{"key":"B47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mus.25653","article-title":"Common polymorphisms of chemokine (C-X3-C Motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: a population-based study","volume":"57","author":"Calvo","year":"2018","journal-title":"Muscle Nerve."},{"key":"B48","doi-asserted-by":"publisher","first-page":"96732","DOI":"10.18632\/oncotarget.18235","article-title":"Targeting Cxcr4 with [68ga]pentixafor: a suitable theranostic approach in pleural mesothelioma?","volume":"8","author":"Lapa","year":"2017","journal-title":"Oncotarget."},{"key":"B49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12149-018-1290-8","article-title":"Cxcr4-directed theranostics in oncology and inflammation","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann Nucl Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2967\/jnumed.118.218008","article-title":"Copper-64 pet imaging of the cxcr4 chemokine receptor using a cross-bridged cyclam bis-tetraazamacrocyclic antagonist","volume":"61","author":"Burke","year":"2020","journal-title":"J Nucl Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2990.2003.00487.x","article-title":"Neurotrophins and neurodegeneration","volume":"29","author":"Dawbarn","year":"2003","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1021\/acschemneuro.9b00144","article-title":"First-in-human brain imaging of [(18)F]Track, a pet tracer for tropomyosin receptor kinases","volume":"10","author":"Bailey","year":"2019","journal-title":"ACS Chem Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ph12010007","article-title":"Radioligands for tropomyosin receptor kinase (Trk) positron emission tomography imaging","volume":"12","author":"Schirrmacher","year":"2019","journal-title":"Pharmaceuticals."},{"key":"B54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jlcr.3827","article-title":"Efficient radiosynthesis and preclinical evaluation of [18 F]fompyd as a positron emission tomography tracer candidate for Trkb\/C receptor imaging","volume":"63","author":"Singleton","year":"2020","journal-title":"J Labell Comp Radiopharm."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","article-title":"Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease","volume":"72","author":"Tuszynski","year":"2015","journal-title":"JAMA Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1089\/hum.2017.069","article-title":"Design of a novel gene therapy construct to achieve sustained brain-derived neurotrophic factor signaling in neurons","volume":"29","author":"Osborne","year":"2018","journal-title":"Hum Gene Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"104590","DOI":"10.1016\/j.nbd.2019.104590","article-title":"Trkb agonistic antibodies superior to bdnf: utility in treating motoneuron degeneration","volume":"132","author":"Guo","year":"2019","journal-title":"Neurobiol Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/brain\/awg138","article-title":"Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A pet study of 44 patients","volume":"126","author":"Hammers","year":"2003","journal-title":"Brain."},{"key":"B59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neulet.2018.08.010","article-title":"Positron emission tomography imaging of the gamma-aminobutyric acid system","volume":"691","author":"Andersson","year":"2019","journal-title":"Neurosci Lett."},{"key":"B60","first-page":"1973","article-title":"Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11c-flumazenil pet study","volume":"46","author":"Yamauchi","year":"2005","journal-title":"J Nucl Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00702-006-0610-7","article-title":"Association of vascular parkinsonism with impaired neuronal integrity in the striatum","volume":"114","author":"Ihara","year":"2007","journal-title":"J Neural Transm."},{"key":"B62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.nucmedbio.2003.09.003","article-title":"Biological evaluation of 2\u2032-[18f]fluoroflumazenil ([18f]Ffmz), a potential gaba receptor ligand for pet","volume":"31","author":"Mitterhauser","year":"2004","journal-title":"Nucl Med Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/123.11.2289","article-title":"Extramotor involvement in Als: pet studies with the Gaba(a) Ligand [11c]Flumazenil","volume":"123","author":"Lloyd","year":"2000","journal-title":"Brain."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00415-006-0482-7","article-title":"Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil pet","volume":"254","author":"Turner","year":"2007","journal-title":"J Neurol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/17482960701737716","article-title":"Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11c)-flumazenil pet study","author":"Wicks","year":"2008","journal-title":"Amyotr Lateral Scler."},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2011.11.039","article-title":"Writing errors in als related to loss of neuronal integrity in the anterior cingulate gyrus","volume":"315","author":"Yabe","year":"2012","journal-title":"J Neurol Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1006\/nimg.2002.1233","article-title":"Evaluation of the reference tissue models for pet and spect benzodiazepine binding parameters","volume":"17","author":"Millet","year":"2002","journal-title":"Neuroimage."},{"key":"B68","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/brain\/120.11.1961","article-title":"Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data","volume":"120","author":"Richardson","year":"1997","journal-title":"Brain."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","article-title":"Differential expression of synaptic vesicle protein 2 (Sv2) isoforms","volume":"14","author":"Bajjalieh","year":"1994","journal-title":"J Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2017.00148","article-title":"Puzzling out synaptic vesicle 2 family members functions","volume":"10","author":"Bartholome","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","article-title":"Synaptic vesicle protein 2a: basic facts and role in synaptic function","volume":"38","author":"Mendoza-Torreblanca","year":"2013","journal-title":"Eur J Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/ejn.12799","article-title":"Synaptic vesicle glycoprotein 2a modulates vesicular release and calcium channel function at peripheral sympathetic synapses","volume":"41","author":"Vogl","year":"2015","journal-title":"Eur J Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing synaptic density in alzheimer disease with synaptic vesicle glycoprotein 2a positron emission tomographic imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/acn3.51407","article-title":"Synaptic density in carriers of C9orf72 mutations: a [(11) C]Ucb-J Pet Study","volume":"8","author":"Malpetti","year":"2021","journal-title":"Ann Clin Transl Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/mds.28216","article-title":"Loss of presynaptic terminal integrity in the substantia nigra in early Parkinson's disease","volume":"35","author":"Delva","year":"2020","journal-title":"Mov Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mds.28188","article-title":"Synaptic loss in primary tauopathies revealed by [(11) C]Ucb-J positron emission tomography","volume":"35","author":"Holland","year":"2020","journal-title":"Mov Disord."},{"key":"B77","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/brain\/awab282","article-title":"Molecular pathology and synaptic loss in primary tauopathies: an 18f-Av-1451 and 11c-Ucb-J Pet Study","volume":"145","author":"Holland","year":"2022","journal-title":"Brain."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/epi.16653","article-title":"Reduced synaptic vesicle protein 2a binding in temporal lobe epilepsy: a [(11) C]Ucb-J positron emission tomography study","volume":"61","author":"Finnema","year":"2020","journal-title":"Epilepsia."},{"key":"B79","doi-asserted-by":"publisher","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2a (Sv2a)","volume":"96","author":"Crowder","year":"1999","journal-title":"Proc Natl Acad Sci U A."},{"key":"B80","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/nan.12054","article-title":"Expression pattern of synaptic vesicle protein 2 (Sv2) Isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis","volume":"40","author":"Crevecoeur","year":"2014","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein Sv2a is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1523\/JNEUROSCI.3805-10.2011","article-title":"Protein quantification at the single vesicle level reveals that a subset of synaptic vesicle proteins are trafficked with high precision","volume":"31","author":"Mutch","year":"2011","journal-title":"J Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","article-title":"Molecular anatomy of a trafficking organelle","volume":"127","author":"Takamori","year":"2006","journal-title":"Cell."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","article-title":"Sv2a and Sv2b function as redundant Ca2+ regulators in neurotransmitter release","volume":"24","author":"Janz","year":"1999","journal-title":"Neuron."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1523\/JNEUROSCI.4781-09.2010","article-title":"Cotrafficking of Sv2 and synaptotagmin at the synapse","volume":"30","author":"Yao","year":"2010","journal-title":"J Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11307-014-0820-6","article-title":"Biodistribution and radiation dosimetry for the novel Sv2a Radiotracer [(18)F]Ucb-H: first-in-human study","volume":"17","author":"Bretin","year":"2015","journal-title":"Mol Imaging Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and preclinical evaluation of 11c-Ucb-J as a pet tracer for imaging the synaptic vesicle glycoprotein 2a in the brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J Nucl Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci Transl Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2967\/jnumed.120.249144","article-title":"First-in-human evaluation of (18)F-Synvest-1, a radioligand for pet imaging of synaptic vesicle glycoprotein 2a","volume":"62","author":"Naganawa","year":"2021","journal-title":"J Nucl Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/acschemneuro.9b00618","article-title":"Synthesis and preclinical evaluation of an (18)F-labeled synaptic vesicle glycoprotein 2a pet imaging probe: [(18)F]Synvest-2","volume":"11","author":"Cai","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11307-020-01567-9","article-title":"Quantification of Sv2a binding in rodent brain using [(18)F]synvest-1 and pet imaging","volume":"23","author":"Sadasivam","year":"2021","journal-title":"Mol Imaging Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.11477\/mf.1416201433","article-title":"The current state of amyotrophic lateral sclerosis\/parkinsonism-dementia complex in the Kii Peninsula, Japan, 2019","volume":"71","author":"Kokubo","year":"2019","journal-title":"Brain Nerve."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/WNL.0000000000006736","article-title":"Tau imaging detects distinctive distribution of tau pathology in Als\/Pdc on the Kii Peninsula","volume":"92","author":"Shinotoh","year":"2019","journal-title":"Neurology."},{"key":"B94","first-page":"313","article-title":"The molecular pathology of frontotemporal lobar degeneration","volume":"112","author":"Fujishiro","year":"2010","journal-title":"Seishin Shinkeigaku Zasshi."},{"key":"B95","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40035-019-0163-y","article-title":"Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the Tdp-43 (G298s) Als Mouse Model","volume":"8","author":"Muller","year":"2019","journal-title":"Transl Neurodegener."},{"key":"B96","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/14737175.2020.1715798","article-title":"Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis","volume":"20","author":"Kassubek","year":"2020","journal-title":"Expert Rev Neurother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/hbm.20527","article-title":"Investigation of white matter pathology in Als and Pls using tract-based spatial statistics","volume":"30","author":"Ciccarelli","year":"2009","journal-title":"Hum Brain Mapp."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1212\/WNL.0b013e3181fb84d1","article-title":"Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis","volume":"75","author":"Filippini","year":"2010","journal-title":"Neurology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/nbm.781","article-title":"Fiber tracking: principles and strategies - a technical review","volume":"15","author":"Mori","year":"2002","journal-title":"NMR Biomed."},{"key":"B100","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fneur.2019.00193","article-title":"White matter microstructure breakdown in the motor neuron disease spectrum: recent advances using diffusion magnetic resonance imaging","volume":"10","author":"Basaia","year":"2019","journal-title":"Front Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","article-title":"Amyotrophic lateral sclerosis\u2013a model of corticofugal axonal spread","volume":"9","author":"Braak","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature."},{"key":"B103","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/jnnp-2017-316365","article-title":"Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker","volume":"89","author":"Kassubek","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.nicl.2018.10.005","article-title":"Cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: a two-centre tract of interest-based DTI analysis","volume":"20","author":"Muller","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B105","doi-asserted-by":"publisher","first-page":"15389","DOI":"10.1038\/s41598-018-33830-z","article-title":"Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data","volume":"8","author":"Gorges","year":"2018","journal-title":"Sci Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/brain\/awu090","article-title":"Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of Tdp-43 pathology","volume":"137","author":"Kassubek","year":"2014","journal-title":"Brain."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s00415-016-8281-2","article-title":"Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study","volume":"263","author":"Rosenbohm","year":"2016","journal-title":"J Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.nicl.2019.101979","article-title":"The same cortico-efferent tract involvement in progressive bulbar palsy and in 'classical' als: a tract of interest-based MRI study","volume":"24","author":"Muller","year":"2019","journal-title":"Neuroimage Clin."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s00415-021-10854-6","article-title":"Involvement of cortico-efferent tracts in flail arm syndrome: a tract-of-interest-based DTI study","volume":"269","author":"Rosenbohm","year":"2022","journal-title":"J Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ana.26045","article-title":"Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis","volume":"89","author":"Hannaford","year":"2021","journal-title":"Ann Neurol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/jnnp-2014-309888","article-title":"Presymptomatic and longitudinal neuroimaging in neurodegeneration\u2013from snapshots to motion picture: a systematic review","volume":"86","author":"Schuster","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3174\/ajnr.A2105","article-title":"Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study","volume":"31","author":"Agosta","year":"2010","journal-title":"Am J Neuroradiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/17482968.2011.593036","article-title":"Progression of white matter degeneration in amyotrophic lateral sclerosis: a diffusion tensor imaging study","volume":"12","author":"Zhang","year":"2011","journal-title":"Amyotroph Lateral Scler."},{"key":"B114","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.nicl.2012.12.003","article-title":"Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis","volume":"2","author":"Kwan","year":"2012","journal-title":"Neuroimage Clin."},{"key":"B115","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fnhum.2014.00270","article-title":"Use of diffusion spectrum imaging in preliminary longitudinal evaluation of amyotrophic lateral sclerosis: development of an imaging biomarker","volume":"8","author":"Abhinav","year":"2014","journal-title":"Front Hum Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.nicl.2016.03.011","article-title":"Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis","volume":"11","author":"Cardenas-Blanco","year":"2016","journal-title":"Neuroimage Clin."},{"key":"B117","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jnnp-2018-318830","article-title":"Neurite orientation and dispersion density imaging (noddi) detects cortical and corticospinal tract degeneration in Als","volume":"90","author":"Broad","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fneur.2018.01065","article-title":"Emerging magnetic resonance imaging techniques and analysis methods in amyotrophic lateral sclerosis","volume":"9","author":"Barritt","year":"2018","journal-title":"Front Neurol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(11)70049-7","article-title":"Towards a neuroimaging biomarker for amyotrophic lateral sclerosis","volume":"10","author":"Turner","year":"2011","journal-title":"Lancet Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1474-4422(15)00134-9","article-title":"Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis","volume":"14","author":"Filippi","year":"2015","journal-title":"Lancet Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/jmri.22186","article-title":"Intercenter differences in diffusion tensor MRI acquisition","volume":"31","author":"Pagani","year":"2010","journal-title":"J Magn Reson Imaging."},{"key":"B122","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/21678421.2014.977297","article-title":"Ex post facto assessment of diffusion tensor imaging metrics from different MRI protocols: preparing for multicentre studies in Als","volume":"16","author":"Rosskopf","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1212\/WNL.0000000000010235","article-title":"A Prospective harmonized multicenter DTI study of cerebral white matter degeneration in Als","volume":"95","author":"Kalra","year":"2020","journal-title":"Neurology."},{"key":"B124","doi-asserted-by":"publisher","first-page":"fcaa061","DOI":"10.1093\/braincomms\/fcaa061","article-title":"Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of Tdp43","volume":"2","author":"Dadar","year":"2020","journal-title":"Brain Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1212\/WNL.0000000000012367","article-title":"Progressive neurochemical abnormalities in cognitive and motor subgroups of amyotrophic lateral sclerosis: a prospective multicenter study","volume":"97","author":"Ta","year":"2021","journal-title":"Neurology."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/hbm.25738","article-title":"Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis","volume":"43","author":"Ishaque","year":"2022","journal-title":"Hum Brain Mapp."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/jmri.26904","article-title":"Reliability of 3d texture analysis: a multicenter MRI study of the brain","volume":"51","author":"Ta","year":"2020","journal-title":"J Magn Reson Imaging."},{"key":"B128","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/WCO.0000000000000737","article-title":"Update on amyotrophic lateral sclerosis genetics","volume":"32","author":"Brenner","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neurobiolaging.2017.05.024","article-title":"Structural and functional brain signatures of C9orf72 in motor neuron disease","volume":"57","author":"Agosta","year":"2017","journal-title":"Neurobiol Aging."},{"key":"B130","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jnnp-2017-316799","article-title":"Longitudinal diffusion imaging across the C9orf72 clinical spectrum","volume":"89","author":"Floeter","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3389\/fneur.2018.01063","article-title":"Biomarkers for amyotrophic lateral sclerosis and frontotemporal dementia associated with hexanucleotide expansion mutations in C9orf72","volume":"9","author":"Floeter","year":"2018","journal-title":"Front Neurol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/jnnp-2016-313959","article-title":"Widespread structural brain involvement in als is not limited to the C9orf72 repeat expansion","volume":"87","author":"Westeneng","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B133","doi-asserted-by":"publisher","first-page":"20406223211002969","DOI":"10.1177\/20406223211002969","article-title":"Segmental involvement of the corpus callosum in C9orf72-associated als: a tract of interest-based DTI study","volume":"12","author":"M\u00fcller","year":"2021","journal-title":"Ther Adv Chronic Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.nicl.2020.102298","article-title":"In vivo histopathological staging in C9orf72-associated als: a tract of interest DTI study","volume":"27","author":"M\u00fcller","year":"2020","journal-title":"NeuroImage Clin."},{"key":"B135","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/21678421.2019.1587634","article-title":"Defining pre-symptomatic amyotrophic lateral sclerosis","volume":"20","author":"Benatar","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B136","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/awab404","article-title":"Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases","volume":"145","author":"Benatar","year":"2021","journal-title":"Brain."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/jnnp-2020-323671","article-title":"Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder","volume":"91","author":"Lul\u00e9","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B138","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ana.25520","article-title":"Presymptomatic spinal cord pathology in C9orf72 mutation carriers: a longitudinal neuroimaging study","volume":"86","author":"Querin","year":"2019","journal-title":"Ann Neurol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2009.01.025","article-title":"Changes of resting state brain networks in amyotrophic lateral sclerosis","volume":"217","author":"Mohammadi","year":"2009","journal-title":"Exp Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e85190","DOI":"10.1371\/journal.pone.0085190","article-title":"Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis","volume":"8","author":"Fekete","year":"2014","journal-title":"PLoS ONE."},{"key":"B141","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neurobiolaging.2014.06.025","article-title":"Functional overlap and divergence between Als and Bvftd","volume":"36","author":"Trojsi","year":"2015","journal-title":"Neurobiol Aging."},{"key":"B142","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1093\/brain\/awr279","article-title":"Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis","volume":"134","author":"Douaud","year":"2011","journal-title":"Brain."},{"key":"B143","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.neurobiolaging.2013.09.041","article-title":"Resting state functional connectivity alterations in primary lateral sclerosis","volume":"35","author":"Agosta","year":"2014","journal-title":"Neurobiol Aging."},{"key":"B144","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neurobiolaging.2012.04.015","article-title":"Divergent brain network connectivity in amyotrophic lateral sclerosis","volume":"34","author":"Agosta","year":"2013","journal-title":"Neurobiol Aging."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045470","article-title":"Patterns of spontaneous brain activity in amyotrophic lateral sclerosis: a resting-state Fmri Study","author":"Luo","year":"2012","journal-title":"PLoS ONE."},{"key":"B146","doi-asserted-by":"publisher","first-page":"38391","DOI":"10.1038\/srep38391","article-title":"Functional connectivity changes resemble patterns of Ptdp-43 pathology in amyotrophic lateral sclerosis","volume":"6","author":"Schulthess","year":"2016","journal-title":"Sci Rep."},{"key":"B147","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.nicl.2020.102509","article-title":"Progression of brain functional connectivity and frontal cognitive dysfunction in Als","volume":"28","author":"Castelnovo","year":"2020","journal-title":"Neuroimage Clin."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/cercor\/bhr002","article-title":"Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis","volume":"21","author":"Agosta","year":"2011","journal-title":"Cereb Cortex."},{"key":"B149","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.nicl.2017.12.025","article-title":"The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis","volume":"17","author":"Menke","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hbm.22258","article-title":"Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis","volume":"35","author":"Verstraete","year":"2014","journal-title":"Hum Brain Mapp."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jmri.24695","article-title":"Reduced structural connectivity within a prefrontal-motor-subcortical network in amyotrophic lateral sclerosis","volume":"41","author":"Buchanan","year":"2015","journal-title":"J Magn Reson Imaging."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e2592","DOI":"10.1212\/WNL.0000000000009498","article-title":"Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis","volume":"94","author":"van der Burgh","year":"2020","journal-title":"Neurology."},{"key":"B153","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuroimage.2015.04.005","article-title":"Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis","volume":"124","author":"Schmidt","year":"2016","journal-title":"Neuroimage."},{"key":"B154","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ana.25706","article-title":"Connectome-based propagation model in amyotrophic lateral sclerosis","volume":"87","author":"Meier","year":"2020","journal-title":"Ann Neurol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2016.00204","article-title":"Altered brain network in amyotrophic lateral sclerosis: a resting graph theory-based network study at voxel-wise level","volume":"10","author":"Zhou","year":"2016","journal-title":"Front Neurosci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/ene.13461","article-title":"Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability","volume":"24","author":"Geevasinga","year":"2017","journal-title":"Eur J Neurol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1212\/wnl.0000000000013123","article-title":"Amyotrophic lateral sclerosis-frontotemporal dementia: shared and divergent neural correlates across the clinical spectrum","volume":"98","author":"Cividini","year":"2021","journal-title":"Neurology."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e2552","DOI":"10.1212\/WNL.0000000000010731","article-title":"Structural and functional brain connectome in motor neuron diseases: a multicenter MRI study","volume":"95","author":"Basaia","year":"2020","journal-title":"Neurology."},{"key":"B159","doi-asserted-by":"publisher","first-page":"701170","DOI":"10.3389\/fneur.2021.701170","article-title":"(1)H Magnetic resonance spectroscopy to understand the biological basis of als, diagnose patients earlier, and monitor disease progression","volume":"12","author":"Caldwell","year":"2021","journal-title":"Front Neurol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11064-017-2248-2","article-title":"Ultra-high field proton MR spectroscopy in early-stage amyotrophic lateral sclerosis","volume":"42","author":"Cheong","year":"2017","journal-title":"Neurochem Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e0177680","DOI":"10.1371\/journal.pone.0177680","article-title":"Ultra high-field (7tesla) magnetic resonance spectroscopy in amyotrophic lateral sclerosis","volume":"12","author":"Atassi","year":"2017","journal-title":"PLoS ONE."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2013.234","article-title":"An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy","volume":"70","author":"Foerster","year":"2013","journal-title":"JAMA Neurol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2019.04.018","article-title":"Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy","volume":"1718","author":"Weerasekera","year":"2019","journal-title":"Brain Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.nicl.2018.08.007","article-title":"Integrated imaging of [(11)C]-Pbr28 pet, MR diffusion and magnetic resonance spectroscopy (1)H-Mrs in amyotrophic lateral sclerosis","volume":"20","author":"Ratai","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B165","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/fnl-2016-0029","article-title":"From qualitative radiological cues to machine learning: MRI-based diagnosis in neurodegeneration","volume":"12","author":"Bede","year":"2017","journal-title":"Futur Neurol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fnins.2019.00135","article-title":"Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions","volume":"13","author":"Grollemund","year":"2019","journal-title":"Front Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"20406223211051002","DOI":"10.1177\/20406223211051002","article-title":"Feature selection from magnetic resonance imaging data in als: a systematic review","volume":"12","author":"Kocar","year":"2021","journal-title":"Ther Adv Chronic Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cortex.2021.11.009","article-title":"Clinicoanatomical substrates of selfish behaviour in amyotrophic lateral sclerosis - an observational cohort study","volume":"146","author":"Lul\u00e9","year":"2022","journal-title":"Cortex."},{"key":"B169","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.nicl.2014.02.011","article-title":"Lessons of als imaging: pitfalls and future directions - a critical review","volume":"4","author":"Bede","year":"2014","journal-title":"Neuroimage Clin."},{"key":"B170","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/WCO.0000000000000569","article-title":"The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools","volume":"31","author":"Bede","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","article-title":"Different partial volume correction methods lead to different conclusions: an (18)F-Fdg-pet study of aging","volume":"132","author":"Greve","year":"2016","journal-title":"Neuroimage."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e0252683","DOI":"10.1371\/journal.pone.0252683","article-title":"Hybrid 2-[18f] Fdg Pet\/MRI in premanifest huntington's disease gene-expansion carriers: the significance of partial volume correction","volume":"16","author":"Hellem","year":"2021","journal-title":"PLoS ONE."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/abf2f7","article-title":"Anatomy-guided pet reconstruction usingl1bowsher prior","author":"Kang","year":"2021","journal-title":"Phys Med Biol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/TBME.2020.3042907","article-title":"Penalized-likelihood pet image reconstruction using 3d structural convolutional sparse coding","volume":"69","author":"Xie","year":"2022","journal-title":"IEEE Trans Biomed Eng."},{"key":"B175","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1002\/mp.15051","article-title":"Anatomically aided pet image reconstruction using deep neural networks","volume":"48","author":"Xie","year":"2021","journal-title":"Med Phys."},{"key":"B176","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1007\/s00330-021-08490-9","article-title":"Individual [(18)F]Fdg Pet and functional MRI based on simultaneous Pet\/MRI may predict seizure recurrence after temporal lobe epilepsy surgery","volume":"32","author":"Wang","year":"2022","journal-title":"Eur Radiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1109\/TMI.2021.3120913","article-title":"Direct reconstruction of linear parametric images from dynamic pet using nonlocal deep image prior","volume":"41","author":"Gong","year":"2022","journal-title":"IEEE Trans Med Imaging."},{"key":"B178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41824-020-00079-7","article-title":"(18)F-Fdg pet-guided diffusion tractography reveals white matter abnormalities around the epileptic focus in medically refractory epilepsy: implications for epilepsy surgical evaluation","volume":"4","author":"Poirier","year":"2020","journal-title":"Eur J Hybrid Imaging."},{"key":"B179","doi-asserted-by":"publisher","first-page":"117221","DOI":"10.1016\/j.neuroimage.2020.117221","article-title":"Ai-driven attenuation correction for brain pet\/MRI: clinical evaluation of a dementia cohort and importance of the training group size","volume":"222","author":"Ladefoged","year":"2020","journal-title":"Neuroimage."},{"key":"B180","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/bs.irn.2018.10.003","article-title":"Hybrid Pet- MRI applications in movement disorders","volume":"144","author":"Tondo","year":"2019","journal-title":"Int Rev Neurobiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/acschemneuro.7b00327","article-title":"In vivo [(18)F]Ge-179 brain signal does not show nmda-specific modulation with drug challenges in rodents and nonhuman primates","volume":"9","author":"Schoenberger","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B182","doi-asserted-by":"publisher","first-page":"823292","DOI":"10.3389\/fmed.2022.823292","article-title":"Impact of tof on brain pet with short-lived (11)C-labeled tracers among suspected patients with Ad\/Pd: using hybrid Pet\/MRI","volume":"9","author":"Wimalarathne","year":"2022","journal-title":"Front Med."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00259-019-04587-y","article-title":"Quantification and discriminative power of (18)F-Fe-Pe2i pet in patients with parkinson's disease","volume":"47","author":"Delva","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B184","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00259-019-04369-6","article-title":"[(11)C]Jnj54173717, a Novel P2x7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2x7 receptors in patients with Parkinson's disease and healthy volunteers","volume":"46","author":"Van Weehaeghe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B185","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12888-021-03063-y","article-title":"The leuven late life depression (L3d) study: pet-MRI biomarkers of pathological brain ageing in late-life depression: study protocol","volume":"21","author":"Emsell","year":"2021","journal-title":"BMC Psychiatry."},{"key":"B186","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7150\/thno.5201","article-title":"Methodology for quantitative rapid multi-tracer pet tumor characterizations","volume":"3","author":"Kadrmas","year":"2013","journal-title":"Theranostics."},{"key":"B187","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s00259-021-05508-8","article-title":"Current human brain applications and challenges of dynamic hyperpolarized carbon-13 labeled pyruvate MR metabolic imaging","volume":"48","author":"Li","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.890425\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:45:44Z","timestamp":1660711544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.890425\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":187,"alternative-id":["10.3389\/fneur.2022.890425"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.890425","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"890425"}}